These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3780056)

  • 1. Antibody to intermediate filaments of the cytoskeleton in patients with Behçet's disease.
    Akoğlu T; Kozakoğlu H; Akoğlu E
    Clin Immunol Immunopathol; 1986 Dec; 41(3):427-32. PubMed ID: 3780056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ninth complement component in rheumatoid arthritis, Behçet's disease and other rheumatic diseases.
    Rumfeld WR; Morgan BP; Campbell AK
    Br J Rheumatol; 1986 Aug; 25(3):266-70. PubMed ID: 3488089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to vimentin intermediate filaments in sera from patients with SLE and RA: quantitation by solid phase radioimmunoassay.
    Alcover A; Ramirez-Lafita F; Hernandez C; Nieto A; Avila J
    J Rheumatol; 1985 Apr; 12(2):233-6. PubMed ID: 3897530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to cytoplasmic intermediate filaments in rheumatic diseases.
    Kurki P; Helve T; Virtanen I
    J Rheumatol; 1983 Aug; 10(4):558-62. PubMed ID: 6352937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofilament antibodies in systemic lupus erythematosus.
    Kurki P; Helve T; Dahl D; Virtanen I
    J Rheumatol; 1986 Feb; 13(1):69-73. PubMed ID: 3517324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies to vimentin-type intermediate filament in patients with progressive systemic sclerosis.
    Tsuneda Y; Kitajima Y; Mori S
    J Dermatol; 1988 Apr; 15(2):128-32. PubMed ID: 3049729
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute phase proteins and C9 in patients with Behcet's syndrome and aphthous ulcers.
    Adinolfi M; Lehner T
    Clin Exp Immunol; 1976 Jul; 25(1):36-9. PubMed ID: 1086750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the prevalence and clinical associations of antibodies to human fibronectin in systemic lupus erythematosus.
    Atta MS; Lim KL; Ala'deen DA; Powell RJ; Todd I
    Ann Rheum Dis; 1995 Feb; 54(2):117-24. PubMed ID: 7702398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybridoma lupus autoantibodies can bind major cytoskeletal filaments in the absence of DNA-binding activity.
    Senécal JL; Rauch J
    Arthritis Rheum; 1988 Jul; 31(7):864-75. PubMed ID: 3293572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptotic keratin bodies as autoantigen causing the production of IgM-anti-keratin intermediate filament autoantibodies.
    Grubauer G; Romani N; Kofler H; Stanzl U; Fritsch P; Hintner H
    J Invest Dermatol; 1986 Oct; 87(4):466-71. PubMed ID: 2428883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A subset of antibodies from the sera of patients with systemic lupus erythematosus react with vimentin and DNA.
    Sánchez A; Ossorio C; Alvaro-Gracia JM; Padilla R; Avila J
    J Rheumatol; 1990 Feb; 17(2):205-9. PubMed ID: 1690805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticytoskeletal autoantibody development in adjuvant arthritis.
    Franch A; Castellote C; Vilà JL; Vilaró S; Castell M
    J Rheumatol; 1994 Mar; 21(3):489-97. PubMed ID: 7516431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis and Behçet's disease.
    Koca SS; Akbulut H; Dag S; Artas H; Isik A
    Tohoku J Exp Med; 2007 Dec; 213(4):297-304. PubMed ID: 18075233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin M autoantibody to vimentin intermediate filaments.
    Senecal JL; Rothfield NF; Oliver JM
    J Clin Invest; 1982 Mar; 69(3):716-21. PubMed ID: 7037855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating immune complexome analysis identified anti-tubulin-α-1c as an inflammation associated autoantibody with promising diagnostic value for Behcet's Disease.
    Cheng Y; Zhao X; Chen Y; Li Y; Jia R; Zhu L; Huang C; Sun X; Deng H; Li Z
    PLoS One; 2018; 13(6):e0199047. PubMed ID: 29902281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies to major and minor nuclear lamins are not restricted to autoimmune diseases.
    Senécal JL; Raymond Y
    Clin Immunol Immunopathol; 1992 May; 63(2):115-25. PubMed ID: 1611714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti asialo GM1 antibody detected in the patients' sera from systemic lupus erythematosus and Behçet's diseases with neurological manifestations.
    Hirano T; Miyajima H; Taniguchi O; Ueda A; Takai S; Hashimoto H; Hirose S; Okumura K
    Jpn J Med; 1988 May; 27(2):167-71. PubMed ID: 3418980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of autoantibodies to killer immunoglobulin-like receptors using recombinant fusion proteins for two killer immunoglobulin-like receptors in patients with systemic autoimmune diseases.
    Matsui T; Otsuka M; Maenaka K; Furukawa H; Yabe T; Yamamoto K; Nishioka K; Kato T
    Arthritis Rheum; 2001 Feb; 44(2):384-8. PubMed ID: 11229470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies to intermediate filaments in acute viral hepatitis A, B and non-A, non-B are directed against vimentin.
    Brown C; Pedersen J; Underwood JR; Gust I; Toh BH
    J Clin Lab Immunol; 1986 Jan; 19(1):1-4. PubMed ID: 3084793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behçet's disease.
    Lee KH; Chung HS; Kim HS; Oh SH; Ha MK; Baik JH; Lee S; Bang D
    Arthritis Rheum; 2003 Jul; 48(7):2025-35. PubMed ID: 12847697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.